Delivery Order SPE2DB24D2216-SPE2DB24FGMMX
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,271.08, is for the delivery of 4567790865 ZILEUTON ER 600 MG TABLET 120S. This is a firm fixed-price delivery order contract with an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.20 Firm Fixed Price delivery order is for the supply of ZYNRELIEF 400-12MG 1S medical products. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. The company holds a significant $999,999,999.00...
This federal contract award, valued at $23,738.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This federal contract award, valued at $6,172.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ZORYVE 0.3% cream, a pharmaceutical product, with a period of performance through June 26, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
This federal contract award, valued at $2,066.40, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This $3,377.27 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on September 27, 2024. The contract is for the supply of medical products, including pharmaceutical medications and medical supplies, to support military treatment facilities and federal healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous contracts by the DLA and other federal agencies to provide a wide range of...
This federal contract award, valued at $43,342.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order contract, which has a firm fixed price pricing type, is for the provision of pharmaceutical products and medical supplies to support the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, is delivering a range of prescription medications,...
This federal contract award, valued at $53,031.18, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of various pharmaceutical products and medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of July 23, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The contract, valued at $257,514.44, is for the delivery of various pharmaceutical products and medical supplies to support military treatment facilities and programs. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of July 17, 2024. Amerisourcebergen, through its Corporate Office Division, has been...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,330.02 firm fixed-price delivery order is for the supply of the pharmaceutical product ZORYVE 0.3% CREAM 60GM. The contract has an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...